ALDH5A1 and central nervous system cancer: Although there are some controversial observations regarding ALDH5A1 expression in glioma, our analysis of multiple patient datasets suggest that ALDH5A1 is significantly downregulated in GBM compared to the normal brain, and its low levels are associated with poor prognosis.